Stockholders approve all proposals at 2024 annual meeting

Lantern Pharma Inc.

Five directors elected: Keyser, Sharma, Chandru, Maccecchini, Silberstein; each received ~3.04M votes for, ~22K withheld.
Amendment to 2018 Equity Incentive Plan approved to increase share pool by 125,000 shares; 2.89M for, 128K against.
Ratification of EisnerAmper LLP as independent auditor for FY2024 passed with 7.17M votes for, 40K against.
Broker non-votes of 4.23M on director election and equity plan; no broker non-votes on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.